Evaluation of Proinflammatory Cytokine Pathway Inhibitors for p38 MAPK Inhibitory Potential

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13551

Full metadata record

DC Field	Value	Language
dc.contributor.author	Paul, Atish Tulshiram	-
dc.date.accessioned	2023-12-29T09:56:16Z	-
dc.date.available	2023-12-29T09:56:16Z	-
dc.date.issued	2007-11	-
dc.identifier.uri	https://pubs.acs.org/doi/full/10.1021/jm0706923	-
dc.identifier.uri	http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13551	-
dc.description.abstract	The target for the anti-inflammatory natural products like amentoflavone (2), which act by interfering with the proinflammatory cytokine pathway (e.g., TNF-α, IL-1β, and NO synthase), is not yet well-defined. Data obtained from docking, electronic, and surface analyses shed some light on steric and electronic complementarity of these molecules to p38 MAPK, thereby suggesting a possible mechanism by which they might reduce the production of proinflammatory cytokines.	en_US
dc.language.iso	en	en_US
dc.publisher	ACS	en_US
dc.subject	Pharmacy	en_US
dc.subject	Inhibitors	en_US
dc.subject	Ligands	en_US
dc.subject	Molecular interactions	en_US
dc.subject	Peptides and proteins	en_US
dc.title	Evaluation of Proinflammatory Cytokine Pathway Inhibitors for p38 MAPK Inhibitory Potential	en_US
dc.type	Article	en_US
Appears in Collections:	Department of Pharmacy

Files in This Item:

There are no files associated with this item.